Skip to main content
Fig. 4 | BMC Ophthalmology

Fig. 4

From: Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

Fig. 4

Right fundus of a 40-year-old woman in the anti-VEGF followed by PSR group. Baseline BCVA of 20/200, -6 D. This patient had one injection for anti-VEGF during treatment and a final BCVA of 20/50. (A) Baseline retinography of CNV diagnosed, (B) 12 months after treatment, (C) 24 months after treatment, no patchy atrophy detected

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us